HK1038516A1 - Serotonergic 5ht2 agonists for treating glaucoma - Google Patents

Serotonergic 5ht2 agonists for treating glaucoma

Info

Publication number
HK1038516A1
HK1038516A1 HK01108810A HK01108810A HK1038516A1 HK 1038516 A1 HK1038516 A1 HK 1038516A1 HK 01108810 A HK01108810 A HK 01108810A HK 01108810 A HK01108810 A HK 01108810A HK 1038516 A1 HK1038516 A1 HK 1038516A1
Authority
HK
Hong Kong
Prior art keywords
serotonergic
agonists
treating glaucoma
glaucoma
treating
Prior art date
Application number
HK01108810A
Other languages
English (en)
Inventor
Jesse A May
Thomas R Dean
Najam A Sharif
Mark R Hellberg
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of HK1038516A1 publication Critical patent/HK1038516A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK01108810A 1998-09-18 2001-12-15 Serotonergic 5ht2 agonists for treating glaucoma HK1038516A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10106798P 1998-09-18 1998-09-18
PCT/US1999/019888 WO2000016761A2 (en) 1998-09-18 1999-09-03 Serotonergic 5ht2 agonists for treating glaucoma

Publications (1)

Publication Number Publication Date
HK1038516A1 true HK1038516A1 (en) 2002-03-22

Family

ID=22282920

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108810A HK1038516A1 (en) 1998-09-18 2001-12-15 Serotonergic 5ht2 agonists for treating glaucoma

Country Status (18)

Country Link
US (2) US6664286B1 (zh)
EP (1) EP1112106B1 (zh)
JP (1) JP2002526443A (zh)
KR (1) KR20010073153A (zh)
CN (1) CN1269484C (zh)
AR (1) AR020442A1 (zh)
AT (1) ATE310566T1 (zh)
AU (1) AU755119B2 (zh)
BR (1) BR9913800A (zh)
CA (1) CA2344150A1 (zh)
DE (1) DE69928542T2 (zh)
DK (1) DK1112106T3 (zh)
ES (1) ES2252978T3 (zh)
HK (1) HK1038516A1 (zh)
TR (1) TR200100754T2 (zh)
TW (1) TWI229602B (zh)
WO (1) WO2000016761A2 (zh)
ZA (1) ZA200102157B (zh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
PL358481A1 (en) * 2000-03-17 2004-08-09 Alcon Inc. 6-hydroxy-indazole derivatives for treating glaucoma
US6956036B1 (en) 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
US6806285B1 (en) 2000-03-17 2004-10-19 Alcon, Inc. 5-Hydroxyl indole derivatives for treating glaucoma
US6927233B1 (en) * 2000-03-17 2005-08-09 Alcon, Inc. 5ht2 agonists for controlling IOP and treating glaucoma
US7005443B1 (en) 2000-03-17 2006-02-28 Alcon, Inc. 5-Hydroxy indazole derivatives for treating glaucoma
WO2001070705A1 (en) 2000-03-17 2001-09-27 Alcon, Inc. 2-acylaminobenzimidazole derivatives for treating glaucoma
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
MXPA02008825A (es) * 2000-03-17 2004-10-15 Alcon Inc Derivados 5-hidroxi indazol para tratamiento de glaucoma.
AU2001216035A1 (en) * 2000-03-17 2001-10-03 Alcon Universal Ltd. 5-hydroxy indole derivatives for treating glaucoma
DE60117247D1 (de) * 2000-03-31 2006-04-20 Purdue Research Foundation West Lafayette Phosphoramidat-prodrugs
WO2002098860A1 (en) 2001-06-01 2002-12-12 Alcon, Inc. Novel fused indazoles and indoles and their use for the treatment of glaucoma
MXPA03010806A (es) 2001-06-01 2004-11-22 Alcon Inc Nuevos analogos de arilaminopropano y su uso para el tratamiento de glaucoma.
KR100626255B1 (ko) 2001-06-01 2006-09-21 알콘, 인코퍼레이티드 피라노인다졸 및 녹내장의 치료를 위한 그의 용도
US6884816B2 (en) * 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
MXPA05002259A (es) * 2002-08-30 2005-07-05 Alcon Inc Compuestos de 5-croman-5-il-etilamina sustituidos y uso para el tratamiento de glaucoma.
EP1558238A4 (en) * 2002-09-24 2006-08-30 Univ Virginia Commonwealth BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA
CA2506204A1 (en) * 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
WO2005053688A1 (en) * 2003-11-26 2005-06-16 Alcon, Inc. Substituted furo[2,3-g] indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
AR046890A1 (es) * 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
EP1744784A2 (en) * 2004-05-11 2007-01-24 Becton, Dickinson and Company Formulations of anti-pain agents and methods of using the same
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
WO2006062839A1 (en) * 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
US20060211700A1 (en) * 2005-03-21 2006-09-21 Alcon, Inc. (R)-8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one for controlling IOP and treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
JP5528699B2 (ja) 2006-05-16 2014-06-25 武田薬品工業株式会社 縮合複素環化合物およびその用途
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
CA2704199C (en) * 2007-11-01 2016-01-19 Acucela Inc. Amine derivative compounds for treating ophthalmic diseases and disorders
EP2216023A4 (en) 2007-11-15 2013-03-13 Takeda Pharmaceutical CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF
US9642819B2 (en) * 2008-07-10 2017-05-09 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
TW201210584A (en) 2010-08-18 2012-03-16 Alcon Res Ltd Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬
US20230000883A1 (en) 2019-04-17 2023-01-05 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
WO2024010765A1 (en) * 2022-07-05 2024-01-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions for treating 5-ht2 conditions and methods of using the same

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
US4659706A (en) 1985-12-20 1987-04-21 Smithkline Beckman Corporation Sulfinyl and sulfonyl substituted 3-benzazepines
US5011846A (en) 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
DE69018332T2 (de) 1989-07-28 1995-10-26 Nippon Oil Co Ltd Verfahren zur kontinuierlichen Herstellung eines Polyethylenmaterials mit hoher Festigkeit und hohem Modul.
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
WO1992020338A1 (en) 1991-05-10 1992-11-26 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
US5571833A (en) 1991-06-21 1996-11-05 Smithkline Beecham Plc Tryptamine analogues, their synthesis and their use as 5-HT1 -like or 5-HT2 receptor agonists
IT1249678B (it) 1991-07-12 1995-03-09 Ciro Costagliola Collirio per il trattamento della ipertensione oculare
GB9216380D0 (en) 1992-07-31 1992-09-16 Glaxo Group Ltd Medicaments
US5290781A (en) 1993-01-05 1994-03-01 Iolab Corporation Ketaneserinol as an agent to reduce intraocular pressure
EP0620222A3 (en) 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-beta-carbolines.
TW334423B (en) 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
TW270114B (zh) 1993-10-22 1996-02-11 Hoffmann La Roche
US5538974A (en) 1994-01-27 1996-07-23 Senju Pharamceutical Co., Ltd. Ophthalmic composition for lowering intraocular pressure
DE69502539T2 (de) 1994-03-18 1998-10-01 Senju Pharma Co Sarpogrelat enthaltende opthalmologische Zubereitungen zur Senkung des intraokularen Druckes
AU5528996A (en) * 1995-03-22 1996-10-08 Eli Lilly And Company Methods of treating or preventing pain or nociception
US5998467A (en) 1995-10-25 1999-12-07 Mitsubishi Chemical Corporation Medicine for oculopathy
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
UA50748C2 (uk) 1995-11-09 2002-11-15 Санофі-Сентелябо Похідні 5-феніл-3(піперидин-4-іл)-1,3,4-оксадіазол-2(3н)ону та фармацевтична композиція
AU2104097A (en) 1996-03-13 1997-10-01 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
DE69710258T2 (de) * 1996-06-17 2002-08-22 Mitsubishi Chem Corp Mittel zur Beschleunigung des Tränenflusses enthaltend einen Serotonin-Liganden, insbesondere Aminoalkoxybibenzyle
WO1998018458A1 (en) * 1996-10-31 1998-05-07 Alcon Laboratories, Inc. Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
EP0958285B1 (en) 1997-01-08 2004-01-07 F.Hoffmann-La Roche Ag TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES
AU5343298A (en) 1997-01-13 1998-08-03 Yamanouchi Pharmaceutical Co., Ltd. 5-ht2c receptor agonists and aminoalkylindazole derivatives
GB9700899D0 (en) 1997-01-17 1997-03-05 Smithkline Beecham Plc Novel treatment
ES2208812T3 (es) 1997-02-25 2004-06-16 Akzo Nobel N.V. Derivados de azetidina y de pirrolidina.
AU727654B2 (en) 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
GB9718833D0 (en) 1997-09-04 1997-11-12 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
BR9913800A (pt) 2001-05-29
CN1269484C (zh) 2006-08-16
WO2000016761A3 (en) 2000-05-25
ATE310566T1 (de) 2005-12-15
CA2344150A1 (en) 2000-03-30
CN1317979A (zh) 2001-10-17
KR20010073153A (ko) 2001-07-31
DE69928542T2 (de) 2006-03-30
AU6132699A (en) 2000-04-10
DE69928542D1 (de) 2005-12-29
JP2002526443A (ja) 2002-08-20
US6664286B1 (en) 2003-12-16
ES2252978T3 (es) 2006-05-16
EP1112106B1 (en) 2005-11-23
TR200100754T2 (tr) 2001-10-22
TWI229602B (en) 2005-03-21
EP1112106A2 (en) 2001-07-04
ZA200102157B (en) 2003-03-05
DK1112106T3 (da) 2005-12-12
AR020442A1 (es) 2002-05-15
US20030203912A1 (en) 2003-10-30
AU755119B2 (en) 2002-12-05
WO2000016761A2 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
HK1038516A1 (en) Serotonergic 5ht2 agonists for treating glaucoma
HUP0201111A3 (en) Shunt device for treating glaucoma
GB9821218D0 (en) Treatment for fabrics
PL348827A1 (en) Process for making 2,3-dihalopropanols
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
PL349504A1 (en) 1,2-annelated quinoline derivatives
GB2344503B (en) Irradiation apparatus for production line use
PL358481A1 (en) 6-hydroxy-indazole derivatives for treating glaucoma
AU4314199A (en) Compounds, compositions and methods for treating erectile dysfunction
HK1040184A1 (zh) 治療青光眼之組合療法
EP1267903A4 (en) METHODS OF TREATING GLAUCOMA
HK1039449A1 (zh) 治療多發性硬化的方法
PL358296A1 (en) 5ht2 agonists for controlling iop and treating glaucoma
IL130531A0 (en) Method for treating glaucoma
HK1042847A1 (zh) 骨代謝異常症治療劑
GB0226147D0 (en) Treatment for multiple sclerosis
HUP0100974A3 (en) Integrated additive composition, process for its preparation and its use
AU1603401A (en) Pyranoindoles for treating glaucoma
GB9917346D0 (en) Medicament for treating premature ejaculation
PL342098A1 (en) Pharmacological compositions for treating diskineses
EP1173312A4 (en) TREATED CLASPS 2
AU3765899A (en) Serotonergic agents
EP1359910A4 (en) PROCESS FOR THE TREATMENT OF GLAUCOM II B
IL141947A0 (en) Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds
HUP0102297A3 (en) Process for preparation of 4,5-epoxymorphinan-6-oxi-glucuronides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100903